Dataset from A Phase III Randomized, Double-blind, Placebo-controlled Multicenter Study in Adults, to Determine the Safety, Efficacy, and Immunogenicity of AZD1222, a Non-replicating ChAdOx1 Vector Vaccine, for the Prevention of COVID-19
收藏NIAID Data Ecosystem2026-05-02 收录
下载链接：
https://doi.org/10.25934/PR00008904
下载链接
链接失效反馈官方服务：
资源简介：
The aim of the study is to assess the safety, efficacy, and immunogenicity of AZD1222 for the
prevention of COVID-19.
创建时间：
2025-02-25
